Apple's iPad the Physician's Favorite: Survey

By Channel Insider Staff  |  Posted 2011-03-14 Email Print this article Print
 
 
 
 
 
 
 

An online marketing firm released the results of a survey that finds that nearly 80 percent of doctors prefer the iPad to other tablets.

With Apple launching its iPad 2 on March 11, Aptilon, an online marketing firm in Montreal, has released the results of a survey revealing that 79 percent of physicians preferred the iPad, while 12 percent would go for a Windows-based tablet and 9 percent for an Android model.

In addition, about 38 percent of physicians plan to buy an iPad in the coming year, and approximately 59 percent of doctors that own an iPad plan to use it for medical purposes.

Aptilon offers a mobile marketing service called AxcelRxSM that allows pharmaceutical, biotech and medical-device firms to advertise and communicate with physicians through the Web on an iPad in real time. Aptilon's ReachNet network allows more than 450,000 health care professionals to connect.

Aptilon interviewed 341 health care professionals in the United States between Feb. 7 and Feb. 16 for the survey.

"The research indicates that the Apple iPad is going to be an ever more important part of an HCP's [health care professional's] daily life as a tool to enhance productivity and remain up to date with the latest developments in their medical field," Aptilon's COO Mark Benthin said in a statement. "As the number of HCPs using iPads increases, Aptilon expects to see increasing opportunities for interactions between industry professionals and HCPs seeking relevant medical content using their tablets."

Everyone from enterprise communication technology specialist Avaya to online health resource WebMD is designing products for the iPad. In fact, the iPad can even help stroke victims communicate.

For more, read the eWEEK article: Apple iPad Is Doctors' First Choice, but Tablet Competition Growing: Survey.

 
 
 
 
 
 
 
 
 
























 
 
 
 
 
 

Submit a Comment

Loading Comments...
























 
 
 
 
 
 
 
 
 
Thanks for your registration, follow us on our social networks to keep up-to-date